Related Experiment Video
Updated: Mar 11, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway
1Department of Neurosurgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No.164 Lanxi Road, Shanghai, 200062 China.
Background:
The aim of this study is to explore the expression of alpha-synuclein (α-synuclein) in benign, atypical, and anaplastic meningiomas and determine its role in the malignant progression of meningiomas.
Methods:
Expression of α-synuclein was measured in 44 meningioma samples by real-time PCR analysis. The effects of overexpression or knockdown of α-synuclein on meningioma cell growth, invasiveness, and tumorigenicity were determined.
Results:
Atypical and anaplastic meningiomas displayed significantly greater levels of α-synuclein mRNA, relative to benign tumors. Depletion of α-synuclein decreased cell proliferation and colony formation and promoted apoptosis in IOMM-Lee meningioma cells, whereas overexpression of α-synuclein facilitated cell proliferation and colony formation in CH-157MN meningioma cells. Silencing of α-synuclein attenuated IOMM-Lee cell migration and invasion. In contrast, ectopic expression of α-synuclein increased the invasiveness of CH-157MN cells. In vivo studies further demonstrated that downregulation of α-synuclein significantly retarded meningioma growth in nude mice. At the molecular level, the phosphorylation levels of Akt, mTOR, p70S6K and 4EBP were significantly decreased in α-synuclein-depleted IOMM-Lee cells.
Conclusions:
In conclusion, α-synuclein upregulation contributes to aggressive phenotypes of meningiomas via the Akt/mTOR pathway and thus represents a potential therapeutic target for malignant meningiomas.
Insights
Alpha-synuclein (α-synuclein) is upregulated in aggressive meningiomas, driving malignant progression. Targeting α-synuclein may offer a new therapeutic strategy for these brain tumors.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Meningiomas are tumors arising from the meninges.
- Malignant progression involves increased cellularity, atypia, and anaplasia.
- The role of alpha-synuclein (α-synuclein) in meningioma tumorigenesis is not well understood.
Purpose of the Study:
- To investigate α-synuclein expression in different grades of meningiomas.
- To determine the functional role of α-synuclein in meningioma cell behavior and tumor growth.
- To explore the molecular pathways involved in α-synuclein-mediated meningioma progression.
Main Methods:
- Real-time PCR analysis of α-synuclein mRNA in 44 meningioma samples.
- In vitro studies assessing the impact of α-synuclein manipulation on cell proliferation, apoptosis, migration, and invasion.
- In vivo xenograft studies in nude mice to evaluate tumor growth.
- Western blot analysis to assess signaling pathway activation.
Main Results:
- Atypical and anaplastic meningiomas showed significantly higher α-synuclein mRNA levels than benign tumors.
- α-synuclein knockdown reduced proliferation, colony formation, and invasion, while promoting apoptosis in meningioma cells.
- α-synuclein overexpression enhanced proliferation, colony formation, and invasion.
- Downregulation of α-synuclein suppressed tumor growth in vivo and reduced Akt/mTOR pathway activation.
Conclusions:
- α-synuclein upregulation is associated with aggressive meningioma phenotypes.
- α-synuclein promotes meningioma cell proliferation, invasion, and survival.
- The Akt/mTOR pathway is implicated in α-synuclein-driven meningioma progression.
- α-synuclein represents a potential therapeutic target for malignant meningiomas.
More Related Videos
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Neural Regulation